Position in MRK
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$3,000,603
+$151,535 QoQ
Shares Held
23,351
-1.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.69%
of 13F equity value
Holder Rank
#1,343
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 20%
Shared 0%
None 80%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MARATHON CAPITAL MANAGEMENT holds $31,900,311 across 10 Drug Manufacturers - General names. MRK ranks #4 (9.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
64,777 | $12,283,014 | |
| 2 | JNJ |
Johnson & Johnson
|
25,121 | $6,379,980 | |
| 3 | NVO |
Novo Nordisk A S
|
78,134 | $3,745,743 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
23,351 | $3,000,603 | |
| 5 | LLY |
ELI LILLY & Co
|
2,492 | $2,988,979 | |
| 6 | ABBV |
AbbVie Inc.
|
6,807 | $1,712,913 | |
| 7 | AMGN |
Amgen Inc
|
2,533 | $917,249 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
8,325 | $479,686 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,000,603 | 23,351 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $2,849,068 | 23,685 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $3,543,577 | 33,665 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $2,866,377 | 34,152 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,733,157 | 34,527 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $3,142,407 | 35,009 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $3,194,700 | 32,114 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,629,831 | 31,964 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $3,969,523 | 32,064 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $4,262,512 | 32,304 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $3,565,390 | 32,704 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $3,405,483 | 33,079 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $3,881,027 | 33,634 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $3,668,752 | 34,484 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $5,075,407 | 45,745 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $4,010,177 | 46,565 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,251,621 | 46,634 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $3,823,037 | 46,594 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $3,532,260 | 46,089 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $3,716,067 | 49,475 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $3,678,832 | 47,304 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,016,740 | 13,189 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,003,194 | 12,264 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $1,017,299 | 12,264 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $978,998 | 12,660 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $978,676 | 12,720 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||